Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-012182
Filing Date
2021-05-14
Accepted
2021-05-14 07:30:35
Documents
46
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20210331_10q.htm 10-Q 556649
2 EXHIBIT 31.1 ex_243438.htm EX-31.1 13068
3 EXHIBIT 31.2 ex_243439.htm EX-31.2 13095
4 EXHIBIT 32.1 ex_243440.htm EX-32.1 6858
11 plxp20210331_10qimg001.gif GRAPHIC 3979
  Complete submission text file 0001437749-21-012182.txt   3191676

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT plxp-20210331.xml EX-101.INS 501590
6 XBRL TAXONOMY EXTENSION SCHEMA plxp-20210331.xsd EX-101.SCH 31130
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20210331_cal.xml EX-101.CAL 31497
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20210331_def.xml EX-101.DEF 262520
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20210331_lab.xml EX-101.LAB 248109
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20210331_pre.xml EX-101.PRE 278577
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 21921939
SIC: 2834 Pharmaceutical Preparations